Blood vessels in a zebrafish brain. Image credit: Childs et al. (CCBY 4.0)
Every time you pause to think, remember a name, or read a sentence, the blood in your brain is quickly rerouted to the neurons doing the work. This redistribution depends on a vast network of blood vessels, from large arteries to microscopic capillaries, which deliver oxygen and energy directly to active brain cells.
For this system to function properly, the smallest blood vessels, the capillaries, must be able to regulate blood flow precisely. This control is provided by support cells on the outside of the capillary, such as pericytes or smooth muscle cells, which relax to open the vessel. When these cells fail, brain regions may no longer receive enough blood, even if larger vessels remain intact.
A breakdown of these cells is observed in cerebral small vessel disease, a leading cause of stroke and dementia. Unlike other types of strokes, this disease originates in the smallest blood vessels of the brain. However, it remains unclear whether it begins only in old age or much earlier in life. Understanding when and how this disease progresses is important because identifying its earliest mechanisms may offer opportunities to delay damage.
Graff et al. studied a zebrafish model carrying a mutation in foxf2a, which is linked to cerebral small-vessel disease in older humans. They found that the condition may not be exclusively age-related. When zebrafish had foxf2a levels reduced to about 50% of normal - similar to the reduction observed in humans with variants linked to cerebral small vessel disease - the fish developed blood vessel absormalities from the earlierst stages of life that persisted into adulthood. They also had fewer pericytes. Although pericytes could regenerate to some extent, blood vessel damage remained and worsened over the lifespan in this zebrafish model.
More detailed analyses revealed that pericytes showed signs of stress, which caused higher rates of cell death compared to zebrafish with normal foxf2a levels. In other words, although blood vessel damage could be partly repaired, it tended to deteriorate when foxf2a was absent.
These findings suggest that cerebral small vessel disease should may be better understood as a lifelong, progressive condition, where damage accumulates over time. Although approximately 20% of the population may carry genetic risk factors for this kind of disease, ongoing blood vessel damage and repair are common. Population-wide screening for individuals at risk of cerebral small vessel disease early in life, combined with targeted lifestyle and cardiovascular interventions, could greatly reduce the disease burden in the elderly.
